BASF, DIEM Labs to pay fine, stop fish oil claim


BASF and DIEM Labs have agreed to pay a $416,000 fine and stop claiming that a fish oil supplement reduced liver fat in patients with non-alcoholic fatty liver disease, in a settlement with the US Federal Trade Commission. "BASF and DIEM couldn't back up serious claims about how Hepaxa capsules would help adults and kids with liver disease,"​ said Daniel Kaufman, Acting Director of the FTC's Bureau of Consumer Protection.

Full story:

Inform SmartBrief

Fats and Oils News

Designed specifically for fats and oils professionals, Inform SmartBrief is a FREE, weekly email newsletter. It provides a summary of global news, research, technology, and trends for the fats and oils community.